Gene · 135152
Papers1,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simultaneous one-pot multienzymatic synthesis and purification of Uridine-5'-Diphosphate-α-D-glucuronide and Uridine-5'-Diphosphate-α-d-xylose. | Carbohydr Res | 2025 | 40383045 | PubTator, text mining | PubMed |
| Nanotechnology in cancer treatment: revolutionizing strategies against drug resistance. | Front Bioeng Biotechnol | 2025 | 40370595 | PubTator, text mining | PubMed |
| Evaluation of search-enabled pretrained Large Language Models on retrieval tasks for the PubChem database. | Bioinform Adv | 2025 | 40365109 | PubTator, text mining | PubMed |
| Potent and highly selective inhibition of selpercatinib towards UDP-glucuronosyltransferase 1A4 (UGT1A4) isoform. | Toxicol Appl Pharmacol | 2025 | 40354983 | PubTator, text mining | PubMed |
| Artificial Intelligence Models and Tools for the Assessment of Drug-Herb Interactions. | Pharmaceuticals (Basel) | 2025 | 40143062 | PubTator, text mining | PubMed |
| Quantitative clinical risk assessment of CYP2C, UDP-glucuronosyltransferase, P-glycoprotein induction, and complex drug-drug interactions using TruVivo human hepatocyte triculture platform. | Drug Metab Dispos | 2025 | 40133023 | PubTator, text mining | PubMed |
| Sex-specific UGT expression and function: prevalence, potential mechanisms and significance. | Expert Opin Drug Metab Toxicol | 2025 | 40081416 | PubTator, text mining | PubMed |
| Efficient protein quantification in drug metabolism and pharmacokinetics with an accelerated proteomic workflow. | Drug Metab Dispos | 2025 | 40068543 | PubTator, text mining | PubMed |
| Inhibitory effects of Kratom constituents, mitragynine and 7-hydroxymitragynine, on 4-methylumbelliferone glucuronidation by human UDP-glucuronosyltransferases. | Toxicol Rep | 2025 | 40026476 | PubTator, text mining | PubMed |
| The Prebiotic Effect of Kaempferol in Regulating Bile Acid Metabolism. | Food Sci Nutr | 2025 | 40008236 | PubTator, text mining | PubMed |
| Lymphovascular Invasion Is Associated With Doxorubicin Resistance in Breast Cancer. | Lab Invest | 2025 | 39978641 | PubTator, text mining | PubMed |
| Identification of human UDP-glucuronosyltransferases involved in I3,II8-biapigenin glucuronidation in Vitro. | J Pharm Biomed Anal | 2025 | 39923326 | PubTator, text mining | PubMed |
| Isoform-level expression of the constitutive androstane receptor (CAR or NR1I3) transcription factor better predicts the mRNA expression of the cytochrome P450s in human liver samples. | Drug Metab Dispos | 2025 | 39884819 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Modeling of Cannabidiol, Delta-9-Tetrahydrocannabinol, and Their Metabolites in Healthy Adults After Administration by Multiple Routes. | Clin Transl Sci | 2025 | 39748462 | PubTator, text mining | PubMed |
| Conjugate Position of Glucuronide and Sulfate in Piceatannol Derivatives Affects the Stability and Hydrolytic Resistance of the Conjugate in Biological Matrices. | J Agric Food Chem | 2025 | 39709555 | PubTator, text mining | PubMed |
| A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer. | Cancer Res | 2025 | 39700396 | PubTator, text mining | PubMed |
| The Metabolic Characteristics and Bioavailability of Resveratrol Based on Metabolic Enzymes. | Nutr Rev | 2025 | 39520710 | PubTator, text mining | PubMed |
| Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury. | Hepatology | 2025 | 39024247 | PubTator, text mining | PubMed |
| [Research progress on in vitro effects of traditional Chinese medicine ingredients on liver UDP-glucuronosyltransferases]. | Zhongguo Zhong Yao Za Zhi | 2024 | 39701723 | PubTator, text mining | PubMed |
| CYP P450 and non-CYP P450 Drug Metabolizing Enzyme Families Exhibit Differential Sensitivities towards Proinflammatory Cytokine Modulation. | Drug Metab Dispos | 2024 | 39349298 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/135152/papers?page=4